Awarded contract

Blood-testing reagents

Details

Value
GBP 162,000
Topic
Blood-testing reagents
Published
12 December 2017

Tender description

Oncotype DX is a test that helps determine the benefit of using chemotherapy in addition to hormone therapy for some oestrogen receptor-positive (ER positive) breast cancers. For the purchase of up to 100 Oncotype DX tests from Genomic Health. These are used within Ocology Services to determine the benefit of using chemotherapy, in addition to hormone therapy for some oestregen receptor-positive breast cancers. NICE has said that Oncotype DX is the only recommended test to help make decisions about chemotherapy after surgery.

Timeline

  1. Completed: Award date10 November 2017
  2. Completed: Award published12 December 2017
    Current notice

About the buyer

NHS Wales - Shared Services Partnership is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33696200 · Blood-testing reagents

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.